Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SHINE: Severe Asthma Covid Vaccine Response Study

NCT05130320 is registered in ClinicalTrials.gov with University Hospital Southampton NHS Foundation Trust as lead sponsor.

NCT NCT05130320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05130320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SHINE: Severe Asthma Covid Vaccine Response Study
Lead sponsor
University Hospital Southampton NHS Foundation Trust
Phase
Observational
Overall status
Unknown status
Start date
May 6, 2021
Completion date
March 31, 2022
Enrollment
250 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus antibody levels